Literature DB >> 15464253

Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.

Rachel E Bullock, Abed M Zaitoun, Guruprasad P Aithal, Stephen D Ryder, Ian J Beckingham, Dileep N Lobo.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15464253     DOI： 10.1016/j.jhep.2004.05.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  23 in total

Review 1.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Sandra K Erickson
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

3.  Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.

Authors:  Noriyuki Koyama; Tomoko Yamazaki; Yuka Kanetsuki; Jiro Hirota; Tomohide Asai; Yasuhide Mitsumoto; Masayuki Mizuno; Toshihide Shima; Yoshihiro Kanbara; Satoko Arai; Toru Miyazaki; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2017-10-30       Impact factor: 7.527

Review 4.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

5.  Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Authors:  Metin Basaranoglu; Sonia M Najjar; Ali Ebag Demirbag; Hakan Senturk
Journal:  World J Hepatol       Date:  2016-03-08

6.  Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

Authors:  Tania M Welzel; Barry I Graubard; Stefan Zeuzem; Hashem B El-Serag; Jessica A Davila; Katherine A McGlynn
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

Review 7.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

Review 8.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

9.  Pathogenesis and Prevention of Hepatic Steatosis.

Authors:  Fatiha Nassir; R Scott Rector; Ghassan M Hammoud; Jamal A Ibdah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-03

10.  Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.

Authors:  Natsuko Kawada; Kazuho Imanaka; Tsukasa Kawaguchi; Chie Tamai; Ryu Ishihara; Takashi Matsunaga; Kunihito Gotoh; Terumasa Yamada; Yasuhiko Tomita
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.